sb 203580 has been researched along with Thrombocytopathy in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akkerman, JW; Bos, JL; Franke, B; Gorter, G; Hackeng, CM; Relou, IA; van Rijn , HJ | 1 |
1 other study(ies) available for sb 203580 and Thrombocytopathy
Article | Year |
---|---|
Low-density lipoprotein activates the small GTPases Rap1 and Ral in human platelets.
Topics: Arachidonic Acid; Blood Platelet Disorders; Blood Platelets; Collagen; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Glutathione Transferase; Humans; Imidazoles; Indomethacin; Ligands; Lipoproteins, LDL; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Phospholipases A; Phosphorylation; Pyridines; ral GTP-Binding Proteins; rap1 GTP-Binding Proteins; Recombinant Fusion Proteins; Signal Transduction; Thrombin; Thromboxane A2; Time Factors | 2000 |